Skip to content

"Effect of Gabapentin in treatment of feeding refusal disorder"

Comparison of the effectiveness of Gabapentin with placebo in feeding improvement in feeding refusal infants age 3 to 6 months

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190410043224N4
Enrollment
64
Registered
2021-02-20
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lnfants feeding refusal disorder. Feeding difficulties

Interventions

Intervention 1: Intervention group:Intervention group: The intervention group includes 32 infants aged 3 to 6 months who have feeding refusal and have no reflux or other acute or chronic disease. Ho

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 6 Months

Inclusion criteria

Inclusion criteria: Age 3 to 6 months The score of reflux questionary 16 or lower Lack of an acute or chronic disease

Exclusion criteria

Exclusion criteria: The score of the reflux questionary greater than 16 Presence of an acute or chronic disease Starting of complementary foods

Design outcomes

Primary

MeasureTime frame
Number of effective breastfeeding. Timepoint: At the beginning of the study and at the end of the second week and the first month. Method of measurement: The number of feedings from the mother's breast that lasts at least 10 minutes or the mother feels empty breasts and the volume of formula to cc.;Volume of formula consumed. Timepoint: Before the intervention, the end of the second week and the end of the first month. Method of measurement: Frequency of breastfeeding that lasts at least 10 minutes or the mother feels empty breasts-volume of formula consumed in mililiter.

Secondary

MeasureTime frame
Restlessness. Timepoint: The end of the first months. Method of measurement: Asking from mother.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Heydari

Esfahan University of Medical Sciences

heydari.pedres@gmail.com+98 31 3386 6266

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026